Bottom line
What is MECVX's expense ratio?
MECVX's expense ratio is 1.42%, or about $142 a year on every $10,000 invested. That is more expensive than 86% of large growth funds we track (median 0.87%). This share class also charges a front-end sales load of up to 5%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Feb 26, 2026
MECVX fee table
| Net expense ratio | 1.42% |
|---|---|
| Gross expense ratio | 1.42% |
| Management fee | 0.75% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.42% |
| Fee waiver / reimbursement | 0% |
| Max front-end sales load | 5% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Feb 26, 2026
What MECVX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| MECVX | $637 | $927 | $1,238 | $2,117 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.42% expense ratio costs roughly $75,800 in lost growth, versus about $48,700 for the median large growth fund (0.87%).